The SARS-COV-2 Seroprevalence among Oncology Patients

Patients with cancer are presumed to be vulnerable to an increased risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and severe clinical outcomes due to the immunocompromised state mediated by their underlying malignancies and therapy. The aim of this study was to estima...

Descripción completa

Detalles Bibliográficos
Autores principales: Kgatle, Mankgopo, Das, Rajesh, Lawal, Ismaheel, Boshomane, Tebatso, Mokoala, Kgomotso, Gaspar, Cattleya, Mbokazi, Lydia, Nkambule, Nonhlanhla, Gow, Veronique, Ndlovu, Honest, Mzizi, Yonwaba, Chalwe, Joseph, Diphofa, Jeaneth, Mokobodi, Dinah, Gxekwa, Nobuhle, Zongo, Lusanda, Maphosa, Tinashe, Vorster, Mariza, Bassa, Sheynaz, Venkatesan, Amouda, Khanyile, Richard, Munga, Yunus, Ebenhan, Thomas, Zeevaart, Jan Rijn, Sathekge, Mike
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9865872/
https://www.ncbi.nlm.nih.gov/pubmed/36675457
http://dx.doi.org/10.3390/jcm12020529

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9865872/
https://www.ncbi.nlm.nih.gov/pubmed/36675457
http://dx.doi.org/10.3390/jcm12020529

Ejemplares similares